lily direct tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Weight Loss Drugs Can Now

It is known for its ability to lighten dark spots, even out skin tone, and reduce inflammation

usually mild and improves within 1-2 weeks of each dose increase Diarrhea Reported by ~15-20% of participants, typically transient Constipation Manageable with adequate hydration and fiber intake Decreased appetite A therapeutic effect rather than a true side effect, though it can feel unfamiliar initially Abdominal discomfort Mild bloating, usually during the first week of a new dose Serious but Rare Risks We review your complete medical history before prescribing

Providers must screen for these conditions before initiation

The studies below highlight the established mechanisms and clinical outcomes of GLP-1 therapy